Almarytm è sicuro? Rischi pro-aritmici e monitoraggi necessari

from staging torrino · host Analisidelsangue Staff

Valutazione dei rischi pro-aritmici di Almarytm, monitoraggi cardiologici e interazioni farmacologicheRead the full article:https://staging.torrinomedica.it/approfondimenti/cardiologia/almarytm-e-sicuro-rischi-pro-aritmici-e-monitoraggi-necessari/

Episode metadata supplied by the publisher feed · Published May 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Almarytm è sicuro? Rischi pro-aritmici e monitoraggi necessari

0:00 3:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Tumor Talks Tumor Talks The idea behind this podcast is to help simplify complex decision making in oncology. There are lots of gray areas and lots of uncertainty in how to treat patients, much of the clinical scenarios we face don’t fall perfectly into the guidelines, so we’re hoping to bridge that gap by bringing experts in all of the fields of oncology to one place - our podcast. Our tumor talks basics series will cover the presentations, staging, and diagnosis of common cancers. Next, we have a case series: describing relatively common but not always straightforward scenarios that practicing oncologists face in practice. We’re going to bring in specialists -medical oncologists mostly – to help shed light on their approach to these clinical cases.

Frequently Asked Questions

How long is this episode of staging torrino?

This episode is 3 minutes long.

When was this staging torrino episode published?

This episode was published on May 26, 2026.

Can I download this staging torrino episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!